Following a shares in issue update for Cambridge Antibody Technology Group PLC (UK), FTSE announces the following changes:
| INDEX | CHANGE | EFFECTIVE FROM
START OF TRADING |
| FTSE All-Share | Cambridge Antibody Technology Group (UK 0166225) will remain in the index with an increased shares in issue total of 51,335,100 and an unchanged investability weighting of 100%. | 31 December 2004 |
| FTSE CAP All-Share | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE All-Share Ex-Multinationals | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE All-Small | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE SmallCap | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE techMARK 100 | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE techMARK All-Share | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE techMARK mediscience | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE4Good UK Index | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
| FTSE ISS UK CGI | Cambridge Antibody Technology Group will be treated as above. | 31 December 2004 |
